Skip to content

Verification of the effects of test food intake on itchy skin

Verification of the effects of test food intake on itchy skin : Placebo-controlled, double-blind, randomized, parallel-group comparison study - Verification of the effects of test food intake on itchy skin : Placebo-controlled, double-blind, randomized, parallel-group comparison study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053005
Enrollment
100
Registered
2023-12-07
Start date
2024-01-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Sponsors

Miura Clinic, Medical Corporation Kanonkai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Subjects of men and women aged 20 to 64 (2) Subject suffering from itchy and dry skin (3) Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing.

Exclusion criteria

Exclusion criteria: (1) Subjects with skin diseases (e.g. atopic dermatitis) according to physician's findings (2) Subjects with diabetes mellitus, liver disease, renal disease, gastrointestinal disease, cardiac disease, respiratory disease, peripheral vascular disease, disease affecting the secretion of adrenal corticosteroids, or other serious diseases, or with pre-existing diseases. (3) Subjects who have undergone gastrointestinal surgery (4) Subjects with diseases currently being treated, or for whom treatment is deemed necessary by the principal investigator or research assistants. (5) Subjects who are allergic to food (especially gelatin) and drugs (6) Female subjects wishing to become pregnant while participating in this study, pregnant (including those who may be pregnant) or lactating female subjects. (7) Subjects who habitually engage in strenuous sports such as marathon running (including professional athletes) and subjects on a diet (8) Subjects with extremely irregular eating habits (9) Subjects who may be exposed to excessive ultraviolet light during the study period. (10) Subjects who visit beauty salons for skin care (11) Subjects who are unable to discontinue consumption of health foods (including food for specified health uses, functional foods, and supplements) and designated quasi-drugs during the study period. (12) Subjects who continue to receive treatment with drugs (including OTC and prescription drugs, e.g., antihistamines, antiallergic agents, cold remedies, topical steroids, etc.) that affect immunity or skin itching or that affect the results of the study (e.g., hypo sensitization therapy) (13) Subjects who have a habit of consuming foods rich in acetic acid bacteria (nigori vinegar, etc.), foods rich in lactic acid bacteria or bifidobacteria (lactic acid bacteria drinks, yogurt, kimchi, etc.), or lactic acid bacteria preparations at least 3 times a week. (14) to (20) are listed in the "Other related information" column.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale

Countries

Japan

Contacts

Public ContactMakoto Terashima

Oneness Support Co., Ltd. Clinical Trial Division

mterashima@oneness-sup.co.jp06-4801-8917

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026